Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA: 603882)

Guangzhou Kingmed Diagnostics Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	16,244	29,331	36,530	51,852	58,870	23,453
Market Cap Growth	-41.08%	-19.71%	-29.55%	-11.92%	151.01%	129.89%
Enterprise Value	15,195	28,042	34,610	50,765	58,143	23,339
Last Close Price	34.95	60.77	74.09	103.91	119.27	47.61
PE Ratio	101.22	44.03	12.56	21.83	36.47	54.10
Forward PE	25.79	31.68	18.29	27.15	55.22	49.31
PS Ratio	2.08	3.43	2.36	4.34	7.14	4.45
PB Ratio	2.07	3.43	4.12	7.95	15.19	10.08
P/TBV Ratio	2.25	3.59	4.32	8.33	16.19	10.75
P/FCF Ratio	30.51	56.83	32.99	45.66	60.54	60.68
P/OCF Ratio	16.59	23.83	18.75	24.83	38.65	35.46
PEG Ratio	1.72	-	3.94	6.79	-	-
EV/Sales Ratio	1.94	3.28	2.24	4.25	7.05	4.43
EV/EBITDA Ratio	21.59	32.63	9.41	16.61	28.14	33.61
EV/EBIT Ratio	130.21	67.58	10.60	18.64	32.57	53.30
EV/FCF Ratio	28.54	54.34	31.26	44.71	59.79	60.39
Debt / Equity Ratio	0.09	0.07	0.06	0.10	0.11	0.26
Debt / EBITDA Ratio	1.01	0.59	0.15	0.20	0.20	0.89
Debt / FCF Ratio	1.34	1.12	0.51	0.55	0.43	1.59
Asset Turnover	0.68	0.67	1.26	1.37	1.49	1.26
Inventory Turnover	20.79	16.60	23.46	21.59	21.46	21.33
Quick Ratio	3.11	2.95	2.22	2.02	1.93	1.56
Current Ratio	3.28	3.07	2.33	2.13	2.06	1.70
Return on Equity (ROE)	1.85%	7.31%	36.95%	45.46%	50.74%	19.40%
Return on Assets (ROA)	0.63%	2.02%	16.57%	19.58%	20.22%	6.55%
Return on Capital (ROIC)	0.81%	2.79%	24.61%	29.77%	30.85%	9.70%
Earnings Yield	0.99%	2.19%	7.54%	4.28%	2.56%	1.72%
FCF Yield	3.28%	1.76%	3.03%	2.19%	1.65%	1.65%
Dividend Yield	2.48%	1.45%	2.40%	1.23%	0.28%	0.29%
Payout Ratio	259.16%	130.46%	22.13%	7.66%	6.09%	21.76%
Buyback Yield / Dilution	0.18%	0.15%	-0.13%	-1.00%	-0.98%	0.07%
Total Shareholder Return	2.65%	1.60%	2.27%	0.23%	-0.71%	0.35%

Source: S&P Capital IQ. Standard template. Financial Sources.